A detailed history of Decision Point Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Decision Point Financial, LLC holds 66 shares of NVO stock, worth $5,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66
Previous 66 -0.0%
Holding current value
$5,854
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$87.78 - $105.45 $2,633 - $3,163
30 Added 83.33%
66 $6,000
Q3 2023

Oct 26, 2023

BUY
$90.94 - $199.54 $1,636 - $3,591
18 Added 100.0%
36 $3.27 Million
Q4 2022

Sep 26, 2023

BUY
$102.55 - $135.33 $1,845 - $2,435
18 New
18 $2.44 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Decision Point Financial, LLC Portfolio

Follow Decision Point Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decision Point Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decision Point Financial, LLC with notifications on news.